目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.1.3 Objectives
1.1.4 Objective - 1
1.1.5 Objective - 2
1.1.6 Objective - 3
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Market Evaluation Methodology:
1.7 List Of Secondary Sources
1.8 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot (Regional)
2.2 Segment Snapshot (Excipient Type)
2.3 Segment Snapshot (Product Application)
2.4 Segment Snapshot (Disease Application)
2.5 Segment Snapshot (Product Industry & Age-based Product)
2.6 Segment Snapshot (Product Industry & Age-based Product)
2.7 Segment Snapshot (End-use)
2.8 Competitive Landscape

Chapter 3 Manufacturers Perspective: Market Variables, Trends, and Scope
3.1 Pharmaceutical Lipid-Based Excipients Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Excipient Market
3.1.2 Ancillary Market Outlook
3.1.2.1 Polymers Excipient Market
3.1.2.2 Sugars Excipient Market
3.1.2.3 Minerals Excipient Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Proliferation of Drug Candidates with Low Water Solubility and Bioavailability Challenges
3.2.1.2 Growing Application of Lipid Excipients in Biologics and RNA-based Therapeutics
3.2.1.3 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
3.2.2 Market Opportunities Analysis
3.2.2.1 Expansion of Pharmaceutical Manufacturing in Emerging Markets as a Growth Opportunity for Lipid Excipients
3.2.2.2 Growth of Local Manufacturers Enhancing Competition and Innovation in the Lipid Excipients Market
3.2.3 Market Restraint Analysis
3.2.3.1 Price Sensitivity in Emerging Markets Restricting the Adoption of Premium Lipid Excipients
3.2.3.2 Market Dominance by Key Players Restricting Entry and Innovation in Lipid Excipients Sector
3.2.4 Market Challenges Analysis
3.2.4.1 Substantial R&D Investment Requirements for Developing Novel Lipid Excipients and Delivery Systems
3.2.4.2 Global Regulatory and Compliance Complexities Adding Operational Challenges for Lipid Excipients Manufacturers
3.3 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
3.3.1 PORTER’S Five Forces Analysis
3.4 Customer Needs, Pains, and Gains Analysis

Chapter 4 Manufacturers Competitive Landscape of Lipid-based Excipients
4.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.2 Company Profiles for Manufacturers of Lipid Excipients
4.2.1 ABITEC (ABF INGREDIENTS).
4.2.1.1 Company Overview
4.2.1.2 Financial Overview
4.2.1.3 Product Overview
4.2.1.4 Key Strategic initiatives
4.2.2 BASF CORPORATION
4.2.2.1 Company Overview
4.2.2.2 Financial Overview
4.2.2.3 Product Overview
4.2.2.4 Strategic Initiatives
4.2.3 GATTEFOSSÉ
4.2.3.1 Company Overview
4.2.3.2 Financial Overview
4.2.3.3 Product Overview
4.2.3.4 Strategic Initiatives
4.2.4 CORDENPHARMA
4.2.4.1 Company Overview
4.2.4.2 Financial Overview
4.2.4.3 Product Overview
4.2.4.4 Strategic Initiatives
4.2.5 LIPOID GMBH
4.2.5.1 Company Overview
4.2.5.2 Financial Overview
4.2.5.3 product Overview
4.2.5.4 Key Strategic Initiatives
4.2.6 IOI OLEO GMBH
4.2.6.1 Company overview
4.2.6.2 Financial Overview
4.2.6.3 Product Overview
4.2.6.4 Strategic initiatives
4.2.7 CRODA INTERNATIONAL PLC
4.2.7.1 Company Overview
4.2.7.2 Financial Overview
4.2.7.3 Product Overview
4.2.7.4 Strategic Initiatives
4.2.8 EVONIK INDUSTRIES AG
4.2.8.1 Company Overview
4.2.8.2 Financial Overview
4.2.8.3 Product Overview
4.2.8.4 Strategic Initiatives
4.2.9 ASHLAND
4.2.9.1 Company Overview
4.2.9.2 Financial Overview
4.2.9.3 Product Overview
4.2.9.4 Strategic Initiatives
4.2.10 MERCK KGAA
4.2.10.1 Company Overview
4.2.10.2 Financial Overview: Thermo Fisher Scientific
4.2.10.3 Product Overview
4.2.10.4 Strategic Initiatives
4.3 Company Market Share Analysis, 2024
4.4 Heatmap analysis

Chapter 5 End User Perspective: Market Variables, Trends, and Scope
5.1 Pharmaceutical Lipid-Based Excipients Market Outlook - End User (Buyer/Consumer Companies) Perspective
5.1.1 Market Driver Analysis
5.1.1.1 Innovation in formulation development
5.1.1.2 End user companies are formulating drugs for pediatric, geriatric, and chronic disease markets
5.1.1.3 The Influence of ESG Objectives on the Adoption of Sustainable Lipid Excipients by End Users
5.1.2 Market Opportunities Analysis
5.1.2.1 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
5.1.2.2 Increasing prevalence of chronic diseases driving demand for lipid based formulations
5.1.3 Market Restraint Analysis
5.1.3.1 High R&D Costs, a Restraint for end use Pharmaceutical Companies Using Lipid-Based Excipients
5.1.3.2 Regulatory Complexity
5.1.4 Market Challenges Analysis
5.1.4.1 Incompatibility with the active pharmaceutical ingredient (API)
5.1.4.2 Stability and Shelf-Life Concerns
5.2 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
5.2.1 PORTER’S Five Forces Analysis

Chapter 6 End User Analysis (Buyer/Consumer Companies) Competitive Landscape
6.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.2 Buyer/Consumer Company Profiles
6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.2.1.1 Company Overview
6.2.1.2 Financial Overview
6.2.1.3 Product Overview
6.2.1.4 Key Strategic initiatives
6.2.2 VIATRIS INC. (FORMERLY MYLAN)
6.2.2.1 Company Overview
6.2.2.2 Financial Overview
6.2.2.3 PRODUCT OVERVIEW
6.2.2.4 Strategic Initiatives
6.2.3 SANDOZ (A DIVISION OF NOVARTIS)
6.2.3.1 Company Overview
6.2.3.2 Financial Overview
6.2.3.3 Product Overview
6.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
6.2.4.1 Company Overview
6.2.4.2 Financial Overview
6.2.4.3 Product Overview
6.2.5 CIPLA LTD.
6.2.5.1 Company Overview
6.2.5.2 Financial Overview
6.2.5.3 product Overview
6.2.5.4 Key Strategic Initiatives
6.2.6 DR. REDDY’S LABORATORIES LTD.
6.2.6.1 Company overview
6.2.6.2 Financial Overview
6.2.6.3 Product Overview
6.2.6.4 Strategic initiatives
6.2.7 AUROBINDO PHARMA LTD.
6.2.7.1 Company Overview
6.2.7.2 Financial Overview
6.2.7.3 Product Overview
6.2.7.4 Strategic Initiatives
6.2.8 LUPIN LTD.
6.2.8.1 Company Overview
6.2.8.2 Financial Overview
6.2.8.3 Product Overview
6.2.9 ZYDUS LIFESCIENCES LTD. (FORMERLY CADILA)
6.2.9.1 Company Overview
6.2.9.2 Financial Overview
6.2.9.3 Product Overview
6.2.9.4 Strategic Initiatives
6.2.10 HIKMA PHARMACEUTICALS PLC
6.2.10.1 Company Overview
6.2.10.2 Financial Overview: Hikma Pharmaceuticals PLC
6.2.10.3 Product Overview
6.3 Heatmap analysis

Chapter 7 Pharmaceutical Lipid-Based Excipients Market, By Excipient Type, 2018 - 2030 (USD Million)
7.1 Pharmaceutical Lipid-Based Excipients Market: Excipient Type Analysis
7.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Excipient Type, 2018 - 2030 (USD Million)
7.2.1 Oils
7.2.1.1 Sesame Oil
7.2.1.2 Soybean Oil
7.2.1.3 Sunflower Oil
7.2.1.4 Linseed Oil /Flaxseed Oil
7.2.1.5 Safflower Oil
7.2.1.6 Coconut Oil
7.2.1.7 Arachis Oil / Peanut Oil
7.2.1.8 Corn Oil / Maize Oil
7.2.1.9 Olive Oil
7.2.1.10 Almond Oil
7.2.1.11 Castor Oil
7.2.1.12 Cotton Seed Oil
7.2.1.13 Grapeseed Oil
7.2.1.14 Other Oils
7.2.2 Hydrogenated Vegetable Oils
7.2.3 GMCC
7.2.4 Hard Fats
7.2.5 Medium Chain Triglycerides (MCTS)
7.2.6 Lecithin And Phospholipids
7.2.7 Sodium Oleate
7.2.8 Capri Caprylic Mono Diglyceride
7.2.9 Other Excipient Types

Chapter 8 Pharmaceutical Lipid-Based Excipients Market, By Product Applications, 2018 - 2030 (USD Million)
8.1 Pharmaceutical Lipid-Based Excipients Market: Product Application Analysis
8.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Application, 2018 - 2030 (USD Million)
8.2.1 Oral Formulations
8.2.1.1 Softgel Capsules
8.2.1.2 Solid Dosage
8.2.1.3 Liquid Oral
8.2.1.4 Solid Lipid Nanoparticles (Slns)
8.2.2 Parenteral
8.2.2.1 Small Volume Parenteral
8.2.2.2 Large Volume Parenteral
8.2.3 Topical Applications
8.2.3.1 Creams
8.2.3.2 Ointments
8.2.3.3 Other Topical Applications
8.2.4 Ophthalmic Applications
8.2.4.1 Eye Drops
8.2.4.2 Ocular Emulsions
8.2.5 Suppositories
8.2.5.1 Rectal Suppositories
8.2.5.2 Vaginal Suppositories
8.2.5.3 Other Suppositories
8.2.6 Other Product Applications

Chapter 9 Pharmaceutical Lipid-Based Excipients Market, By Disease Application, 2018 - 2030 (USD Million)
9.1 Pharmaceutical Lipid-Based Excipients Market: Disease Application Analysis
9.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Disease Application, 2018 - 2030 (USD Million)
9.2.1 Cardiovascular Diseases
9.2.2 Neurological Disorders
9.2.3 Oncology
9.2.4 Metabolic Disorders
9.2.5 Hormonal Therapies
9.2.6 Infectious Diseases
9.2.7 Other Disease Applications

Chapter 10 Pharmaceutical Lipid-Based Excipients Market, By Product Industry, 2018 - 2030 (USD Million)
10.1 Pharmaceutical Lipid-Based Excipients Market: Product Industry Analysis
10.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Industry, 2018 - 2030 (USD Million)
10.2.1 Pharmaceutical (OTC & RX)
10.2.2 Nutraceutical (Dietary Supplements & Other)

Chapter 11 Pharmaceutical Lipid-Based Excipients Market, By Age-Based Product, 2018 - 2030 (USD Million)
11.1 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product Analysis
11.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Age-Based Product, 2018 - 2030 (USD Million)
11.2.1 Pediatric Products (0-18 Years)
11.2.2 Adult Products (19-64 Years)
11.2.3 Geriatric Products (65+ Years)

Chapter 12 Pharmaceutical Lipid-Based Excipients Market, By End-Use, 2018 - 2030 (USD Million)
12.1 Pharmaceutical Lipid-Based Excipients Market: End-Use Product Analysis
12.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by End-Use, 2018 - 2030 (USD Million)
12.2.1 Pharmaceutical Manufacturers
12.2.2 Contract Development And Manufacturing Organizations (CDMOS)
12.2.3 Other

Chapter 13 Pharmaceutical Lipid-Based Excipients Market: Regional Estimates and Trend Analysis
13.1 Pharmaceutical Lipid-Based Excipients Market: Regional Outlook
13.2 North America
13.2.1 North America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.2.2 U.S.
13.2.2.1 Key Country Dynamics
13.2.2.2 U.S. Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.2.2.3 Competitive/Market Scenario
13.2.2.4 Regulatory Framework
13.2.3 Canada
13.2.3.1 Key Country Dynamics
13.2.3.2 Canada Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.2.3.3 Competitive/Market Scenario
13.2.3.4 Regulatory Framework
13.2.4 Mexico
13.2.4.1 Key Country Dynamics
13.2.4.2 Mexico Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.2.4.3 Competitive/Market Scenario
13.2.4.4 Regulatory Framework
13.3 Europe
13.3.1 Europe Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.3.2 UK
13.3.2.1 Key Country Dynamics
13.3.2.2 UK pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.2.3 Competitive/Market Scenario
13.3.2.4 Regulatory Framework
13.3.3 Germany
13.3.3.1 Key Country Dynamics
13.3.3.2 Germany pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.3.3 Competitive/Market Scenario
13.3.3.4 Regulatory Framework
13.3.4 France
13.3.4.1 Key Country Dynamics
13.3.4.2 France pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.4.3 Competitive/Market Scenario
13.3.4.4 Regulatory Framework
13.3.5 Italy
13.3.5.1 Key Country Dynamics
13.3.5.2 Italy pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.5.3 Competitive/Market Scenario
13.3.5.4 Regulatory Framework
13.3.6 Spain
13.3.6.1 Key Country Dynamics
13.3.6.2 Spain pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.6.3 Competitive/Market Scenario
13.3.6.4 Regulatory Framework
13.3.7 Norway
13.3.7.1 Key Country Dynamics
13.3.7.2 Norway Pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.7.3 Competitive/Market Scenario
13.3.7.4 Regulatory Framework
13.3.8 Sweden
13.3.8.1 Key Country Dynamics
13.3.8.2 Sweden pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.3.8.3 Competitive/Market Scenario
13.3.8.4 Regulatory Framework
13.3.9 Denmark
13.3.9.1 Key Country Dynamics
13.3.9.2 Denmark Pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
13.3.9.3 Competitive/Market Scenario
13.3.9.4 Regulatory Framework
13.3.10 Rest Of Europe Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.4 Asia Pacific
13.4.1 Asia Pacific Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.4.2 China
13.4.2.1 Key Country Dynamics
13.4.2.2 China pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.4.2.3 Competitive/Market Scenario
13.4.2.4 Regulatory Framework
13.4.3 India
13.4.3.1 Key Country Dynamics
13.4.3.2 India pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.4.3.3 Competitive/Market Scenario
13.4.3.4 Regulatory Framework
13.4.4 South Korea
13.4.4.1 Key Country Dynamics
13.4.4.2 South Korea pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
13.4.4.3 Competitive/Market Scenario
13.4.4.4 Regulatory Framework
13.4.5 Rest Of Asia Pacific Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.5 Latin America
13.5.1 Latin America Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.5.2 Brazil
13.5.2.1 Key Country Dynamics
13.5.2.2 Brazil pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.5.2.3 Competitive/Market Scenario
13.5.2.4 Regulatory Framework
13.5.3 Argentina
13.5.3.1 Key Country Dynamics
13.5.3.2 Argentina pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.5.3.3 Competitive/Market Scenario
13.5.3.4 Regulatory Framework
13.5.4 Rest Of Latin America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6 MEA
13.6.1 MEA Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.6.2 South Africa
13.6.2.1 Key Country Dynamics
13.6.2.2 South Africa Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.2.3 Competitive/Market Scenario
13.6.2.4 Regulatory Framework
13.6.3 Saudi Arabia
13.6.3.1 Key Country Dynamics
13.6.3.2 Saudi Arabia pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.3.3 Competitive/Market Scenario
13.6.3.4 Regulatory Framework
13.6.4 UAE
13.6.4.1 Key Country Dynamics
13.6.4.2 UAE pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.4.3 Competitive/Market Scenario
13.6.4.4 Regulatory Framework
13.6.5 Jordan
13.6.5.1 Key Country Dynamics
13.6.5.2 Jordan pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.5.3 Competitive/Market Scenario
13.6.5.4 Regulatory Framework
13.6.6 Egypt
13.6.6.1 Key Country Dynamics
13.6.6.2 Egypt pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.6.3 Competitive/Market Scenario
13.6.6.4 Regulatory Framework
13.6.7 Iran
13.6.7.1 Key Country Dynamics
13.6.7.2 Iran pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.7.3 Competitive/Market Scenario
13.6.7.4 Regulatory Framework
13.6.8 Kuwait
13.6.8.1 Key Country Dynamics
13.6.8.2 Kuwait pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
13.6.8.3 Competitive/Market Scenario
13.6.8.4 Regulatory Framework
13.6.9 Rest Of MEA Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 14 Competitive Landscape
14.1. Market Participant Categorization
14.2. Company Market Position Analysis/ Heap Map Analysis
14.3. Strategy Mapping
14.3.1. Mergers & Acquisitions
14.3.2. Partnerships & Collaborations
14.3.3. Others
14.4. Company Profiles
14.4.1. ABITEC Corporation
14.4.2. BASF
14.4.3. Gattefossé
14.4.4. CordenPharma
14.4.5. Lipoid
14.4.6. IOI Oleo GmbH
14.4.7. Croda International
14.4.8. Evonik Industries
14.4.9. Ashland
14.4.10. Merck KGaA

List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Company market share, 2024
Table 4. Projected number of adults 50 years and older with chronic disease in the U.S. (in Million)
Table 5. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by excipient type, 2018 - 2030 (USD Million)
Table 6. Oil excipient market analysis
Table 7. Sesame oil excipient market analysis
Table 8. Soybean excipient market analysis
Table 9. Sunflower excipient market analysis
Table 10. Linseed oil /flaxseed oil excipient market analysis
Table 11. Safflower oil excipient market analysis
Table 12. Coconut oil excipient market analysis
Table 13. Peanut oil excipient market analysis
Table 14. Corn oil/ maize oil excipient market analysis
Table 15. Olive oil excipient market analysis
Table 16. Almond oil excipient market analysis
Table 17. Castor oil excipient market analysis
Table 18. Cotton seed oil excipient market analysis
Table 19. Grape seed oil excipient market analysis
Table 20. Cotton seed oil excipient market analysis
Table 21. Hydrogenated vegetable oils excipient market analysis
Table 22. GMCC excipient market analysis
Table 23. Hard fat vegetable oils excipient market analysis
Table 24. MCT excipient market analysis
Table 25. Lecithin and phospholipids excipient market analysis
Table 26. Sodium oleate excipient market analysis
Table 27. Capri caprylic mono diglyceride excipient market analysis
Table 28. Other types excipient market analysis
Table 29. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product application, 2018 - 2030 (USD Million)
Table 30. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by Disease application, 2018 - 2030 (USD Million)
Table 31. Global heart & circulatory disease prevalence in 2021 and deaths 2021
Table 32. Global risk factors for heart & circulatory diseases (CVD)
Table 33. Alzheimer’s disease prevalence in various countries
Table 34. Parkinson’s disease prevalence in various countries
Table 35. New cases and deaths for 36 cancers and all cancers combined in 2022
Table 36. Incidence and mortality rates (age-standardized rate per 100,000, cumulative risk) for 24 world areas and by sex for all cancers combined (including nonmelanoma skin cancer except basal cell carcinoma) in 2022.
Table 37. Estimated number, percentage, and awareness of prediabetes among adults aged 18 years or older, U.S., 2017 - 2020 and 2021
Table 38. Global diabetes data report 2000 - 2045
Table 39. Prevalence of some of the endocrine disorders in 2022
Table 40. Global and regional estimates of TB incidence, numbers (in thousands) and rates (per 100 000 population) in 2023
Table 41. Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2023
Table 42. Subgroup analysis of the prevalence of Dry Eye Disorder in Asia
Table 43. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product industry, 2018 - 2030 (USD Million)
Table 44. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by age-based product, 2018 - 2030 (USD Million)
Table 45. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by end-use, 2018 - 2030 (USD Million)
Table 46. Key lipid excipients manufacturers in the U.S.
Table 47. Key end user of lipid excipients in the U.S.
Table 48. Key lipid excipients manufacturers in the Canada
Table 49. Key end user of lipid excipients in the Canada
Table 50. Key lipid excipients manufacturers in the Mexico
Table 51. Key end user of lipid excipients in the Mexico
Table 52. Key lipid excipients manufacturers in the UK
Table 53. Key end user of lipid excipients in the UK
Table 54. Key lipid excipients manufacturers in the Germany
Table 55. Key end user of lipid excipients in the Germany
Table 56. Key lipid excipients manufacturers in the France
Table 57. Key end user of lipid excipients in the France
Table 58. Key lipid excipients manufacturers in Itay.
Table 59. Key End users of lipid excipients in Italy
Table 60. Key lipid excipients manufacturers in Spain.
Table 61. Key End users of lipid excipients in Spain
Table 62. Key lipid excipients manufacturers in the Norway.
Table 63. Key End users of lipid excipients in the Norway
Table 64. Key lipid excipients manufacturers in Sweden.
Table 65. Key End users of lipid excipients in Sweden
Table 66. Key lipid excipients manufacturers in Denmark.
Table 67. Key End users of lipid excipients in Denmark
Table 68. Key lipid excipients manufacturers in China.
Table 69. Key End users of lipid excipients in China
Table 70. Key lipid excipients manufacturers in India.
Table 71. Key End users of lipid excipients in India
Table 72. Key lipid excipients manufacturers in the South Korea
Table 73. Key end user of lipid excipients in the South Korea
Table 74. Key lipid excipients manufacturers in Brazil.
Table 75. Key End users of lipid excipients in Brazil
Table 76. Key lipid excipients manufacturers in Argentina.
Table 77. Key End users of lipid excipients in Argentina
Table 78. Key lipid excipients manufacturers in South Africa.
Table 79. Key End users of lipid excipients in South Africa
Table 80. Key lipid excipients manufacturers in Saudi Arabia.
Table 81. Key End users of lipid excipients in Saudi Arabia
Table 82. Key lipid excipients manufacturers in UAE.
Table 83. Key End users of lipid excipients in UAE
Table 84. Key lipid excipients manufacturers in Jordan.
Table 85. Key End users of lipid excipients in Jordan
Table 86. Key lipid excipients manufacturers in Egypt.
Table 87. Key End users of lipid excipients in Egypt
Table 88. Key lipid excipients manufacturers in Iran.
Table 89. Key End users of lipid excipients in Iran
Table 90. Key End users of lipid excipients in Kuwait

List of Figures
Fig. 1 Pharmaceutical lipid-based excipients market: Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot (Excipient type)
Fig. 10 Segment snapshot (Product Application)
Fig. 11 Segment snapshot (Disease Application)
Fig. 12 Segment snapshot (Product industry & age-based product)
Fig. 13 Segment snapshot (Product industry & age-based product)
Fig. 14 Segment snapshot (End-use)
Fig. 15 Competitive landscape
Fig. 16 Excipients market estimates and forecast, 2018-2030, USD Million
Fig. 17 Market dynamics
Fig. 18 Porter’s five forces analysis
Fig. 19 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
Fig. 20 Company market share analysis, 2024
Fig. 21 Heatmap analysis
Fig. 22 Porter’s five forces analysis
Fig. 23 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
Fig. 24 Heatmap analysis
Fig. 25 Pharmaceutical Lipid-Based Excipients Market: Excipient Type outlook and key takeaways
Fig. 26 Pharmaceutical Lipid-Based Excipients Market: Excipient type movement analysis
Fig. 27 Oils market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Sesame oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Soybean oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Sunflower oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Linseed oil /flaxseed oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Safflower oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Coconut oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Arachis oil / peanut oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Corn oil / maize oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Olive oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Almond oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Castor oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Grapeseed oil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Other oils market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Hydrogenated vegetable oils market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 GMCC market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hard fats market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Medium Chain triglycerides (MCTs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Lecithin and phospholipids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Sodium oleate market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Capri caprylic mono diglyceride market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Other excipient types market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Pharmaceutical Lipid-Based Excipients Market: Product Application outlook and key takeaways
Fig. 50 Pharmaceutical Lipid-Based Excipients Market: Product application movement analysis
Fig. 51 Oral formulations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Softgel capsules market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Solid dosage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Small volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Large volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Topical applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Creams market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Other topical applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Ophthalmic applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Ocular emulsions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Rectal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Vaginal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Other Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Other product applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Pharmaceutical Lipid-Based Excipients Market: Disease Application outlook and key takeaways
Fig. 72 Pharmaceutical Lipid-Based Excipients Market: Disease Application movement analysis
Fig. 73 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Hormonal therapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Other disease applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Pharmaceutical Lipid-Based Excipients Market Product Industry outlook and key takeaways
Fig. 81 Pharmaceutical Lipid-Based Excipients Market: Product Industry movement analysis
Fig. 82 Pharmaceutical (OTC & Rx) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Nutraceutical (dietary supplements & other) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Pharmaceutical Lipid-Based Excipients Market Age-Based Product outlook and key takeaways
Fig. 85 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product movement analysis
Fig. 86 Pediatric products (0-18 years) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Adult products (19-64 years) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Geriatric products (65+ years) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Pharmaceutical Lipid-Based Excipients Market End-Use outlook and key takeaways
Fig. 90 Pharmaceutical Lipid-Based Excipients Market: End-Use Product movement analysis
Fig. 91 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Contract Development and Manufacturing Organizations (CDMOs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Pharmaceutical Lipid-Based Excipients Market, revenue, by region, 2024 & 2030 (USD million)
Fig. 95 Regional marketplace: Key takeaways
Fig. 96 Regional marketplace: Key takeaways
Fig. 97 North America pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 U.S. pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD million)
Fig. 100 Key country dynamics
Fig. 101 Canada pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Mexico pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030, USD Million
Fig. 104 Europe pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 UK pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Germany pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 France pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Italy pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 Spain pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 Norway pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Key country dynamics
Fig. 118 Sweden pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 119 Key country dynamics
Fig. 120 Denmark pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Rest of Europe pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 122 Asia Pacific pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 China pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 125 Key country dynamics
Fig. 126 India pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 South Korea pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 129 Rest of Asia Pacific pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 130 Latin America pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 131 Key country dynamics
Fig. 132 Brazil pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 133 Key country dynamics
Fig. 134 Argentina pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 135 Rest of Latin America pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 136 MEA pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 137 Key country dynamics
Fig. 138 South Africa pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 139 Key country dynamics
Fig. 140 Saudi Arabia pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 141 Key country dynamics
Fig. 142 UAE pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 143 Key country dynamics
Fig. 144 Jordan pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 145 Key country dynamics
Fig. 146 Egypt pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 147 Key country dynamics
Fig. 148 Iran pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 149 Key country dynamics
Fig. 150 Kuwait pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 151 Rest of MEA pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)